Exogenous and endogenous glucocorticoids in rheumatic diseases
Open Access
- 8 October 2010
- journal article
- review article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 63 (1) , 1-9
Abstract
No abstract availableThis publication has 56 references indexed in Scilit:
- Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2010
- Glucocorticoid-mediated Inhibition of Lck Modulates the Pattern of T Cell Receptor-induced Calcium Signals by Down-regulating Inositol 1,4,5-Trisphosphate ReceptorsJournal of Biological Chemistry, 2009
- Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptorRheumatology, 2009
- Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseasesBritish Journal of Pharmacology, 2009
- Overnight variations in cortisol, interleukin 6, tumour necrosis factor α and other cytokines in people with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2009
- Local and systemic glucocorticoid metabolism in inflammatory arthritisAnnals of the Rheumatic Diseases, 2008
- Glucocorticoids exert opposing effects on macrophage function dependent on their concentrationImmunology, 2007
- Glucocorticoids cause rapid dissociation of a T‐cell‐receptor‐associated protein complex containing LCK and FYNEMBO Reports, 2006
- Circadian rhythms in RAAnnals of the Rheumatic Diseases, 2003
- Circadian rhythm of serum interleukin-6 in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1994